SCHEMBL7089036

SCHEMBL7089036

CNc1nc(S(C)(=O)=O)c(-c2ccnc(Nc3cccc([N+](=O)[O-])c3)n2)s1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 13/20 0.78
CCNT1 O60563 10/20 0.78
CDK9 P50750 10/20 0.78
CDK1 P06493 8/20 0.78
CCNB1 P14635 8/20 0.78
CDK4 P11802 7/20 0.78
CCNA2 P20248 7/20 0.78
CDK7 P50613 7/20 0.78
CCNH P51946 7/20 0.78
CCNA1 P78396 6/20 0.78
ABL1 P00519 4/20 0.62
AURKA O14965 1/20 0.62
CCNB2 O95067 1/20 0.62
CCNE2 O96020 1/20 0.62
CCND1 P24385 1/20 0.62
CCNE1 P24864 1/20 0.62
ABL2 P42684 1/20 0.62
GSK3B P49841 1/20 0.62
MNAT1 P51948 1/20 0.62
CDK5 Q00535 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2282051 0.87 CDK2 (1.00) CDK2CCNT1CDK9CDK1CCNB1
SCHEMBL6684173 0.86 CDK2 (0.63) CDK2CCNT1CDK9CDK1CCNB1
SCHEMBL1807318 0.82 CDK2 (0.79) CDK2CCNT1CDK9CDK1CCNB1
SCHEMBL6156443 0.78 CDK2 (1.00) CDK2CCNT1CDK9CDK1CCNB1
SCHEMBL29354713 0.78 CDK2 (1.00) CDK2CCNT1CDK9CDK1CCNB1
SCHEMBL4167919 0.78 CDK2 (0.82) CDK2CCNT1CDK9CDK1CCNB1
SCHEMBL20817070 0.78 CDK2 (0.79) CDK2CCNT1CDK9CDK1CCNB1
SCHEMBL2086977 0.78 CDK2 (0.73) CDK2CCNT1CDK9CDK1CCNB1
SCHEMBL4795797 0.77 CDK2 (0.81) CDK2CCNT1CDK9CDK1CCNB1
SCHEMBL4386032 0.77 CDK2 (0.72) CDK2CCNT1CDK9CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1274705-A1 2-SUBSTITUTED 4-HETEROARYL-PYRIMIDINES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2003-01-15 EP disclosed
WO-2001072745-A1 2-SUBSTITUTED 4-HETEROARYL-PYRIMIDINES AND THEIR USE IN THE TREATMETN OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2001-10-04 WO disclosed